Skip to main content
Log in

Predictive models for lymph node metastases in patients with testicular germ cell tumors

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose: To develop predictive models for lymph node (LN) metastasis in testicular germ cell tumors. Materials and Methods: 291 patients with testicular germ cell tumors were included, which were divided into seminomatous and nonseminomatous groups. For screening the risk factors for LN metastasis, the tumor-related characteristics (including histopathological information and tumor markers) alpha fetoprotein and the lymph node-related features on CT were compared between metastatic cases and nonmetastatic cases. Two logistic regression models were built for each histological group, one depending on all tumor- and lymph node-related risk factors (Model 1) and another only on tumor-related factors (Model 2). Receivers operating characteristic curves were used to evaluate the predictive abilities of these models. Results: 117 positive nodes/regions were identified in 68 patients, including 51 metastases and 17 occult metastases. Based on the selected independent risk factors, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of Models 1 and 2 in seminomatous and nonseminomatous groups were (95.5%, 95.3%, 95.3%, 77.8%, and 99.2%), (63.6%, 83.6%, 80.7%, 40.0%, and 93.0%), (93.5%, 94.7%, 94.3%, 89.6%, and 96.8%), and (89.1%, 44.2%, 58.9%, 43.6%, and 89.4%), respectively. Conclusion: Two predictive models for each seminomatous and nonseminomatous testicular tumor were established based on lymph node- and tumor-related risk factors. In patients with tumor and lymph node-related risk factors, regular CT surveillance is likely sufficient for predicting LN status, while in the patients without any tumor and lymph node-related risk factors a long interval-time CT follow-up should be considered. Additionally, right side tumors tend to involve contralateral LNs compared to left side ones. Positive inguinal LNs more frequently occur in patients with a history of groin surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170(1):5–11. doi:10.1097/01.ju.0000053866.68623.da

    Article  PubMed  Google Scholar 

  2. Bosl GJ, Geller NL, Cirrincione C, et al. (1983) Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43(7):3403–3407

    CAS  PubMed  Google Scholar 

  3. Aparicio J, Germà JR, García del Muro X, et al. (2005) Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23(34):8717–8723. doi:10.1200/JCO.2005.01.9810

    Article  PubMed  Google Scholar 

  4. Albers P, Siener R, Kliesch S, et al. (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21(8):1505–1512. doi:10.1200/JCO.2003.07.169

    Article  PubMed  Google Scholar 

  5. Hoskin P, Dilly S, Easton D, et al. (1986) Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4(7):1031–1036

    CAS  PubMed  Google Scholar 

  6. Droz JP, Kramar A, Ghosn M, et al. (1988) Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis. Cancer 62(3):564–568

    Article  CAS  PubMed  Google Scholar 

  7. Stoter G, Sylvester R, Sleijfer DT, et al. (1987) Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study. Cancer Res 47(10):2714–2718

    CAS  PubMed  Google Scholar 

  8. Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al. (2001) Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 19(7):2020–2025

    CAS  PubMed  Google Scholar 

  9. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW (1998) Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83(5):1002–1011

    Article  CAS  PubMed  Google Scholar 

  10. Warde P, Gospodarowicz MK, Banerjee D, et al. (1997) Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 157(5):1705–1709. (discussion 1709–1710).

  11. Warde P, Specht L, Horwich A, et al. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20(22):4448–4452

    Article  PubMed  Google Scholar 

  12. Dong P, Liu Z-W, Li X-D, et al. (2013) Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors. Med Oncol Northwood Lond Engl 30(1):494. doi:10.1007/s12032-013-0494-y

    Article  Google Scholar 

  13. Vergouwe Y, Steyerberg EW, Eijkemans MJC, Albers P, Habbema JDF (2003) Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 21(22):4092–4099. doi:10.1200/JCO.2003.01.094

    Article  PubMed  Google Scholar 

  14. Fung CY, Kalish LA, Brodsky GL, Richie JP, Garnick MB (1988) Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol 6(9):1467–1473

    CAS  PubMed  Google Scholar 

  15. Klepp O, Olsson AM, Henrikson H, et al. (1990) Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 8(3):509–518

    CAS  PubMed  Google Scholar 

  16. Aass N, Klepp O, Cavallin-Stahl E, et al. (1991) Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 9(5):818–826

    CAS  PubMed  Google Scholar 

  17. Williams SB, Kacker R, Winston D, et al. (2011) Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. J Urol 186(6):2245–2248. doi:10.1016/j.juro.2011.07.101

    Article  CAS  PubMed  Google Scholar 

  18. Vesprini D, Chung P, Tolan S, et al. (2012) Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 118(21):5245–5250. doi:10.1002/cncr.27539

    Article  CAS  PubMed  Google Scholar 

  19. Hermans BP, Sweeney CJ, Foster RS, Einhorn LE, Donohue JP (2000) Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol 163(6):1721–1724

    Article  CAS  PubMed  Google Scholar 

  20. Moul JW, McCarthy WF, Fernandez EB, Sesterhenn IA (1994) Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 54(2):362–364

    CAS  PubMed  Google Scholar 

  21. Hilton S, Herr HW, Teitcher JB, Begg CB, Castéllino RA (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. Am J Roentgenol 169(2):521–525. doi:10.2214/ajr.169.2.9242768

    Article  CAS  Google Scholar 

  22. Ray B, Hajdu SI, Whitmore WF (1974) Proceedings: distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 33(2):340–348

    Article  CAS  PubMed  Google Scholar 

  23. Albers P, Albrecht W, Algaba F, et al. (2012) EAU guidelines on testicular cancer: 2011 update. Eur Assoc Urol 36(3):127–145 (Actas Urol Esp). doi:10.1016/j.acuro.2011.06.017

    CAS  Google Scholar 

  24. Scatarige JC, Fishman EK, Kuhajda FP, Taylor GA, Siegelman SS (1983) Low attenuation nodal metastases in testicular carcinoma. J Comput Assist Tomogr 7(4):682–687

    Article  CAS  PubMed  Google Scholar 

  25. Hansen J, Jurik AG (2009) Diagnostic value of multislice computed tomography and magnetic resonance imaging in the diagnosis of retroperitoneal spread of testicular cancer: a literature review. Acta Radiol 50(9):1064–1070. doi:10.3109/02841850903220371

    Article  CAS  PubMed  Google Scholar 

  26. Leibovitch L, Foster RS, Kopecky KK, Donohue JP (1995) Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 154(5):1759–1763

    Article  CAS  PubMed  Google Scholar 

  27. Paño B, Sebastià C, Buñesch L, et al. (2011) Pathways of lymphatic spread in male urogenital pelvic malignancies. Radiographics 31(1):135–160. doi:10.1148/rg.311105072

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandeep Hedgire.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, Y., Hedgire, S., Prapruttam, D. et al. Predictive models for lymph node metastases in patients with testicular germ cell tumors. Abdom Imaging 40, 3196–3205 (2015). https://doi.org/10.1007/s00261-015-0526-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-015-0526-5

Keywords

Navigation